Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05224141 |
|---|---|
| Brief Title: | Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008) |
| First Submitted : | January 25, 2022 |
| First Submitted that Met QC Criteria : | January 25, 2022 |
| First Posted : | February 4, 2022 |
| Last Update Submitted that Met QC Criteria : | March 3, 2023 |
| Last Update Posted : | March 7, 2023 |